A phase III study of TAS-118 plus oxaliplatin versus S-1 plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (SOLAR study)-Reference-Cited by-同舟云学术

A phase III study of TAS-118 plus oxaliplatin versus S-1 plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (SOLAR study)

Published:2019-07 Issue: Volume:30 Page:iv153
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kang Y.,Chin K.,Chung H.,Kadowaki S.,Oh S.,Nakayama N.,Lee K.,Hara H.,Chung I.,Tsuda M.,Park S.,Hosaka H.,Hironaka S.,Miyata Y.,Ryu M.,Takeuchi M.,Baba H.,Hyodo I.,Bang Y.,Boku N.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/30/Supplement_4/mdz183.002/28915591/mdz183.002.pdf

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of conversion surgery following immune checkpoint inhibitors and chemotherapy in stage IV gastric cancer;International Journal of Surgery;2023-09-14

2. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study;Gastric Cancer;2020-11-11

3. Upcoming first-line chemotherapy for HER2-negative gastric cancer in Japan: which patients benefit from immunotherapy?;Future Oncology;2020-08

4. WJOG10517G: a multicenter Phase II study of mFOLFOX6 in gastric cancer patients with severe peritoneal metastases;Future Oncology;2020-07

5. Phase I Study of Alternate-Day Administration of S-1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer;The Oncologist;2020-06-17